Viyash has ten manufacturing facilities in India with a combined capacity of 2000 KL as well as one formulation facility in the US, and is now one of India’s leading mid-tier integrated API and formulation players
Solara Active Pharma Sciences has reported consolidated financial results for the period ended September 30, 2021.
Strides Pharma Science has reported consolidated financial results for the period ended September 30, 2021
The company’s pharmaceutical API products Ibuprofen and fenofibrate got the go-ahead
The company plans to expand its portfolio in regulated markets aggressively
The new devices company will scale up its teams to create a world-class R&D centre for medical devices in India
CuraTeQ Biologics is on track for filing a second oncology biosimilar
In H1FY21, it attracted PE deals worth US $ 1.6 billion compared to US $ 3 billion in CY2020
The acquisition was expected to be completed in eight weeks, and it would have provided it with a foothold in the US $ 48 billion global animal health market
The acquisition will provide it with a foothold in the US $ 48 billion global animal health market
Subscribe To Our Newsletter & Stay Updated
